The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index; 9 of the 35 sources its claims cite were checked for support.
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A
Open accessAbstract
Reactivation of fetal hemoglobin (HbF) in adults ameliorates the severity of the common β-globin disorders. The transcription factor BCL11A is a critical modulator of hemoglobin switching and HbF silencing, yet the molecular mechanism through which BCL11A coordinates the developmental switch is incompletely understood. Particularly, the identities of BCL11A cooperating protein complexes and their roles in HbF expression and erythroid development remain largely unknown. Here we determine the interacting partner proteins of BCL11A in erythroid cells by a proteomic screen. BCL11A is found within multiprotein complexes consisting of erythroid transcription factors, transcriptional corepressors, and chromatin-modifying enzymes. We show that the lysine-specific demethylase 1 and repressor element-1 silencing transcription factor corepressor 1 (LSD1/CoREST) histone demethylase complex interacts with BCL11A and is required for full developmental silencing of mouse embryonic β-like globin genes and human γ-globin genes in adult erythroid cells in vivo. In addition, LSD1 is essential for normal erythroid development. Furthermore, the DNA methyltransferase 1 (DNMT1) is identified as a BCL11A-associated protein in the proteomic screen. DNMT1 is required to maintain HbF silencing in primary human adult erythroid cells. DNMT1 haploinsufficiency combined with BCL11A deficiency further enhances γ-globin expression in adult animals. Our findings provide important insights into the mechanistic roles of BCL11A in HbF silencing and clues for therapeutic targeting of BCL11A in β-hemoglobinopathies.
Overview
CoChat Summary
TL;DR
BCL11A silences fetal hemoglobin by assembling multiprotein corepressor complexes in erythroid cells, including LSD1/CoREST, NuRD, and DNMT1. Genetic and RNAi experiments show these partners contribute to γ-globin/embryonic β-like globin silencing, but LSD1 and DNMT1 also have broader roles that limit their therapeutic targeting.
Key findings
- A proteomic affinity screen in MEL and K562 erythroid cells identified BCL11A-interacting proteins including the LSD1/CoREST histone demethylase complex, NuRD complex, SIN3, NCoR/SMRT, BCOR, DNMT1, and SWI/SNF; interactions were confirmed by co-IP in primary human erythroid cells.
- In primary human CD34+ HSPC-derived erythroid cells, shRNA knockdown of BCL11A-interacting corepressors increased γ-globin; top-ranked genes included NuRD subunits (CHD4, HDAC1, HDAC2, MBD2), DNMT1, SIN3A, NCOR1, and PRC2 subunits (EZH2, EED, SUZ12). Depletion of KLF1, but not BCL11A, significantly increased ε-globin.
- LSD1/CoREST loss derepressed mouse embryonic β-like globins: E12.5 Lsd1 KO increased εy- and βh1-globin 6.2- and 26.7-fold; E13.5 CoREST KO increased them 13.0- and 15.4-fold; adult Mx1-Cre LSD1 cKO increased them 5.8- and 10.6-fold. BCL11A deletion caused much greater increases (31.2- to 232.9-fold).
- Compound BCL11A/LSD1 loss further enhanced γ-globin: Bcl11a−/−::Lsd1+/− mice had 13.53% γ-globin versus 8.40% in Bcl11a−/− mice (P = 0.0006); Bcl11a−/−::Lsd1−/− mice had 18.19% versus 12.88% with BCL11A loss alone (P = 0.03). DNMT1 haploinsufficiency plus BCL11A deficiency increased γ-globin from 11.16% to 23.58% (2.1-fold, P = 1.9 × 10−6).
Methods
- Proteomic screen: stable MEL and K562 lines expressing BirA alone or FLAG-BirA-tagged BCL11A XL isoform; streptavidin and/or anti-FLAG affinity purification followed by LC-MS/MS, with co-IP validation in erythroid cells.
- Functional RNAi screen: lentiviral shRNAs targeting BCL11A or interacting proteins in primary adult human CD34+ HSPCs undergoing ex vivo erythroid maturation; qRT-PCR for globin expression, with shRNAs achieving >75% target mRNA knockdown selected.
- Chromatin and mouse genetics: ChIP-qPCR in primary human adult erythroid cells with control or BCL11A knockdown; conditional floxed Lsd1, Rcor1, Bcl11a, and Dnmt1 alleles crossed with EpoR-Cre or Mx1-Cre, including β-YAC transgenic mice, analyzed by qRT-PCR and hematology.
Limitations
- Stated: primary human erythroid cultures have higher background γ-globin than normal adult erythroid cells and CD34+ HSPCs are permissive for HbF induction, making them sensitive but not necessarily specific; growth kinetics and differentiation status affect HbF. β-YAC mice have far lower baseline transgenic γ-globin than normal individuals, so interventions face a greater quantitative hurdle, and effects are small compared with BCL11A KO.
- Stated: LSD1 and DNMT1 have broad roles in hematopoiesis; LSD1 KO is embryonic lethal with severe anemia, and complete DNMT1 loss is incompatible with normal hematopoietic development, suggesting a narrow therapeutic window.
- Evident from the text: RNAi effects may reflect incomplete knockdown, and compound KO experiments used heterozygous Lsd1 or Dnmt1 in some settings because homozygous loss causes lethality, so full loss-of-function contributions were not always tested.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
8 Valid · 1 Not valid · 15 Not checked · 97 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Subsequent studies demonstrated that BCL11A, a zinc- fi nger transcription factor, is a bona fi de repressor of HbF expression (4 -7).”
What the sources say
- Not checked — no full text of the sourcecites [4] source
- Supportedcites [5] source
The section headed “Silencing of human γ-globin expression depends on BCL11A” reports that loss of BCL11A markedly impairs developmental silencing of human γ-globin genes in mice carrying the human β-globin locus. The Concluding Remarks also state that BCL11A acts to silence γ-globin expression after birth in humans, supporting its description as a repressor of fetal hemoglobin expression. (LLM, conf=0.94)
- Supportedcites [6] source
The Abstract identifies BCL11A as a zinc-finger transcription factor and reports that reducing it in adult human erythroid precursors robustly induces HbF. The Discussion describes BCL11A’s role in silencing γ-globin genes, supporting its characterization as an HbF repressor. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [7] source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In control cells, ChIP analysis revealed that BCL11A occupies several discrete regions within the human β -globin cluster, including the DNase I hypersensitive site 3 (HS3) within the locus control region (LCR), the e -globin promoter, and the γδ -intergenic region, consistent with previous analyses (4, 6).”
What the sources say
- Not checked — no full text of the sourcecites [4] source
- Supportedcites [6] source
The section “BCL11A occupies the human β-globin cluster in vivo” reports ChIP-chip binding at LCR sites, embryonic ε-globin, and the Aγ–δ intergenic region in primary adult human erythroid progenitors. The section “BCL11A, SOX6, and GATA1 co-occupy the human β-globin cluster” specifically identifies HS3 and the ε-globin promoter among BCL11A-occupied sites. Page numbers are unavailable in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, its roles in other cell lineages, including B lymphocytes and the central nervous system, may present challenges (19, 20).”
What the sources say
- Not checked — no full text of the sourcecites [19] Liu P, et al. (2003) Bcl11a is essential for normal lymphoid development. Nat Immunol 4(6):525 -532. source
- Supportedcites [20] Leid M, et al. (2004) CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. Gene Expr Patterns 4(6):733 -739. source
The Abstract identifies CTIP1 as BCL11A and reports that CTIP1-deficient mice lack B cells. It also reports CTIP1 expression in the developing and adult central nervous system and supports a contribution to CNS function. The possibility that these roles may present challenges is the citing authors’ inference. (LLM, conf=0.90)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Consistent with a role in HbF silencing, knockdown or KO of Mi-2 β reactivates γ -globin genes in the β -YAC transgenic mice (23, 24).”
What the sources say
- Supportedcites [23] Costa FC, Fedosyuk H, Chazelle AM, Neades RY, Peterson KR (2012) Mi2 β is required for γ -globin gene silencing: Temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β -YAC transgenic mice. PLoS Genet 8(12):e1003155. source
The Results section ('Expression of γ-globin in Mi2β conditional knockout β-YAC mice'; page not specified) reports increased human γ-globin expression after conditional Mi2β knockout in β-YAC mice. This source supports the knockout part of the citing sentence; it need not establish knockdown separately. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [24] Amaya ML, et al. (2013) Mi2 β -mediated silencing of the fetal γ -globin gene in adult erythroid cells. Blood , 10.1182/blood-2012-11-466227. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study also shows that DNMT1 haploinsuf fi ciency augments HbF expression elicited by BCL11A de fi ciency.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
88 more claims
Create a free account to see all 121 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 11
Citations
Cites
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Self-citationMiller, I. J., & Bieker, J. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2776 · Cited by 723
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation
Jackson-Grusby, L., Beard, C., Possemato, R., Tudor, M., Fambrough, D., Csankovszki, G., Dausman, J., Lee, P., Wilson, C., Lander, E., et al. (2001) · Nature Genetics · doi:10.1038/83730 · Cited by 694
5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia
Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072401 · Cited by 490
Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications
Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G., & Shiekhattar, R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.004 · Cited by 438
Control of globin gene expression during development and erythroid differentiation
Stamatoyannopoulos, G. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.11.007 · Cited by 393
5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.
DeSimone, J., Heller, P., Hall, L., & Zwiers, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.14.4428 · Cited by 384 · cited 1×
“DNA methylation plays an important role in globin gene expression, and DNA demethylating agents have been shown to induce HbF expression in various model systems and patients (8, 17, 18).”
BackgroundDevelopmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379
Self-citationTrowbridge, J. J., Snow, J. W., Kim, J., & Orkin, S. H. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.08.016 · Cited by 373
Self-citation
Cited by
An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Science · doi:10.1126/science.1242088 · Cited by 653
Self-citationDirect promoter repression by BCL11A controls the fetal to adult hemoglobin switch
Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478
“As the N terminus contains a canonical NuRDbinding peptide (Lejon et al., 2011), NuRD is present in protein complexes with BCL11A (Xu et al., 2013), and downregulation of NuRD subunits induces HbF expression (Gnanapragasam Cell 173, 430–442, April 5, 2018 431 (A) Heatmaps depict results of…”
BackgroundSelf-citationReactivation of developmentally silenced globin genes by forced chromatin looping
Deng, W., Rupon, J. W., Krivega, I., Breda, L., Motta, I., Jahn, K. S., Reik, A., Gregory, P. D., Rivella, S., Dean, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.050 · Cited by 443
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Masuda, T., Wang, X., Maeda, M., Canver, M. C., Sher, F., Funnell, A. P. W., Fisher, C., Suciu, M., Martyn, G. E., Norton, L. J., et al. (2016) · Science · doi:10.1126/science.aad3312 · Cited by 373
Self-citationIn Situ Capture of Chromatin Interactions by Biotinylated dCas9
Liu, X., Zhang, Y., Chen, Y., Li, M., Zhou, F., Li, K., Cao, H., Ni, M., Liu, Y., Gu, Z., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.003 · Cited by 315
Self-citation
Metadata
- Authors
- Xu, J., Bauer, D. E., Kerenyi, M. A., Vo, T. D., Hou, S., Hsu, Y.-J., Yao, H., Trowbridge, J. J., Mandel, G., & Orkin, S. H.
- Affiliations
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Orkin, Stuart H.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-04
- Volume
- 110
- Issue
- 16
- Pages
- 6518-6523
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3631619
- OpenAlex
- W2161143576
- Cited by
- 233
- References
- 29
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 17 · 2023: 16 · 2022: 15 · 2021: 30 · 2020: 20 · 2019: 12 · 2018: 19 · 2017: 20 · 2016: 24 · 2015: 16 · 2014: 12 · 2013: 8
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL032259)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK049216, K01DK093543, P30DK056465, K08DK093705)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- BCL11A, hemoglobin switching, erythroid development, histone demethylation, DNMT1, DNA methylation, corepressors, beta-globin gene, γ-globin expression, β-hemoglobinopathies, protein-protein interaction
- MeSH terms
- Animals, Carrier Proteins, Chromatin, Chromatography, Liquid, Fetal Hemoglobin, Humans, Nuclear Proteins, Repressor Proteins, Erythroid Precursor Cells, Gene Expression Regulation, Developmental, RNA Interference, Proteomics, Cell Line, Tumor, Multiprotein Complexes, Chromatin Immunoprecipitation, Mice, Tandem Mass Spectrometry, beta-Globins, Co-Repressor Proteins, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. https://app.cochat.ai/papers/10.1073/pnas.1303976110
- The paper
- Xu, J., Bauer, D. E., Kerenyi, M. A., Vo, T. D., Hou, S., Hsu, Y.-J., Yao, H., Trowbridge, J. J., Mandel, G., & Orkin, S. H. (2013). Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1303976110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.